CURE

Direxion Daily Healthcare Bull 3x Shares

CURE Fund Description

The Direxion Daily Healthcare Bull ETF provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies.

CURE Factset Analytics Insight

As a levered product, CURE is not a buy-and-hold ETF; it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare names—like J&J, Pfizer, and Merck—in the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. CURE's expense ratio is high but, as a short-term product, yearly fees are less important than trading costs. Liquidity is decent, although spreads can be volatile. Check the latest Tradability data on this page.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
12:59:4745.00100
12:51:3145.00100
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

CURE Factset Analytics Block Liquidity

As of 11/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of CURE. CURE is rated a 5 out of 5.

CURE Summary Data

Direxion
06/15/11
Open-Ended Fund
1.09%
$141.51M
0.07%

CURE Portfolio Data

0.00%
12/19/17

CURE Index Data

Market Cap
Committee
N/A

CURE Fund Structure

Yes
No
No Policy
N/A
N/A
Low
3
Daily

CURE Tax Exposures

20% / 39.6%
--
No

CURE Tradability

106,458
$4.87M
96,954
$4.47M
0.07%
-0.05%
1.09% / -0.29%
None
50,000
1.94
0.01%
1,181
$44.79
5